These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae. Zhou Y; Wang J; Guo Y; Liu X; Liu S; Niu X; Wang Y; Deng X J Infect; 2019 May; 78(5):364-372. PubMed ID: 30851289 [TBL] [Abstract][Full Text] [Related]
27. Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model. Yu Y; Walsh TR; Yang RS; Zheng M; Wei MC; Tyrrell JM; Wang Y; Liao XP; Sun J; Liu YH J Antimicrob Chemother; 2019 Jan; 74(1):87-95. PubMed ID: 30346547 [TBL] [Abstract][Full Text] [Related]
28. Recent progress on elucidating the molecular mechanism of plasmid-mediated colistin resistance and drug design. Kai J; Wang S Int Microbiol; 2020 Aug; 23(3):355-366. PubMed ID: 31872322 [TBL] [Abstract][Full Text] [Related]
29. Increased colistin resistance upon acquisition of the plasmid-mediated mcr-1 gene in Escherichia coli isolates with chromosomally encoded reduced susceptibility to polymyxins. Jayol A; Nordmann P; André C; Dubois V; Poirel L Int J Antimicrob Agents; 2017 Sep; 50(3):503-504. PubMed ID: 28729123 [No Abstract] [Full Text] [Related]
30. Diacylglycerol Kinase A Is Essential for Polymyxin Resistance Provided by EptA, MCR-1, and Other Lipid A Phosphoethanolamine Transferases. Purcell AB; Voss BJ; Trent MS J Bacteriol; 2022 Feb; 204(2):e0049821. PubMed ID: 34843376 [TBL] [Abstract][Full Text] [Related]
31. Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. Dong H; Xiang H; Mu D; Wang D; Wang T Int J Antimicrob Agents; 2019 Jan; 53(1):1-8. PubMed ID: 30267758 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Quan J; Li X; Chen Y; Jiang Y; Zhou Z; Zhang H; Sun L; Ruan Z; Feng Y; Akova M; Yu Y Lancet Infect Dis; 2017 Apr; 17(4):400-410. PubMed ID: 28139430 [TBL] [Abstract][Full Text] [Related]
33. Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States. Mediavilla JR; Patrawalla A; Chen L; Chavda KD; Mathema B; Vinnard C; Dever LL; Kreiswirth BN mBio; 2016 Aug; 7(4):. PubMed ID: 27578755 [TBL] [Abstract][Full Text] [Related]
34. The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis. Fantin B; Poujade J; Grégoire N; Chau F; Roujansky A; Kieffer N; Berleur M; Couet W; Nordmann P Clin Microbiol Infect; 2019 Dec; 25(12):1563.e5-1563.e8. PubMed ID: 31494253 [TBL] [Abstract][Full Text] [Related]
35. Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman. Mohsin J; Pál T; Petersen JE; Darwish D; Ghazawi A; Ashraf T; Sonnevend A Microb Drug Resist; 2018 Apr; 24(3):278-282. PubMed ID: 28799833 [TBL] [Abstract][Full Text] [Related]
36. Resistance to polymyxins in Gram-negative organisms. Jeannot K; Bolard A; Plésiat P Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137 [TBL] [Abstract][Full Text] [Related]
37. Lack of experimental evidence to support mcr-1-positive Escherichia coli strain selection during oral administration of colistin at recommended and higher dose given by gavage in weaned piglets. Viel A; Henri J; Perrin-Guyomard A; Laroche J; Couet W; Grégoire N; Laurentie M Int J Antimicrob Agents; 2018 Jan; 51(1):128-131. PubMed ID: 28668687 [TBL] [Abstract][Full Text] [Related]
38. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. Rosenthal KS; Storm DR J Antibiot (Tokyo); 1977 Dec; 30(12):1087-92. PubMed ID: 202585 [TBL] [Abstract][Full Text] [Related]
39. MCR-1 Confers Cross-Resistance to Bacitracin, a Widely Used In-Feed Antibiotic. Xu F; Zeng X; Hinenoya A; Lin J mSphere; 2018 Sep; 3(5):. PubMed ID: 30185515 [TBL] [Abstract][Full Text] [Related]
40. Kieffer N; Royer G; Decousser JW; Bourrel AS; Palmieri M; Ortiz De La Rosa JM; Jacquier H; Denamur E; Nordmann P; Poirel L Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]